These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 6270051

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.
    Digranes A, Benonisen E, Dibb WL.
    Infection; 1982; 10(5):307-9. PubMed ID: 6293978
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic and microbial susceptibility studies of ceftriaxone.
    Baumgartner JD, Glauser MP.
    Eur J Clin Microbiol; 1983 Oct; 2(5):501-4. PubMed ID: 6315426
    [Abstract] [Full Text] [Related]

  • 4. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
    Emmerson AM, Lamport PA, Reeves DS, Bywater MJ, Holt HA, Wise R, Andrews J, Hall MJ.
    Curr Med Res Opin; 1985 Oct; 9(7):480-93. PubMed ID: 3928265
    [Abstract] [Full Text] [Related]

  • 5. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
    Jones RN, Barry AL, Thornsberry C.
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
    Blandino G, Milazzo I, Musumeci R, Nicolosi VM, Speciale A, Nicoletti G.
    J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
    [Abstract] [Full Text] [Related]

  • 8. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
    Beskid G, Siebelist J, McGarry CM, Cleeland R, Chan K, Keith DD.
    Chemotherapy; 1990 Dec; 36(2):109-16. PubMed ID: 2107064
    [Abstract] [Full Text] [Related]

  • 9. Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin.
    Machka K, Dietz R.
    Eur J Clin Microbiol; 1983 Oct; 2(5):496-500. PubMed ID: 6315425
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R, Gutmann L, Kitzis MD, Goldstein F, Acar JF.
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [Abstract] [Full Text] [Related]

  • 12. Oral absorption of cephalosporin antibiotics. 3. Synthesis and biological properties of 7 alpha-methoxy-7 beta-(arylacetamido)-3-chloro-3-cephem-4- carboxylic acids.
    Pfeil-Doyle J, Kukolja S.
    J Med Chem; 1988 Oct; 31(10):1997-2000. PubMed ID: 3050090
    [Abstract] [Full Text] [Related]

  • 13. Third generation oral cephalosporins: comparative in vitro kinetics.
    Speciale A, Blandino G, Nicoletti G.
    J Chemother; 1995 May; 7 Suppl 1():9-12. PubMed ID: 8618112
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014.
    Pfaller MA, Mendes RE, Castanheira M, Flamm RK, Jones RN, Sader HS.
    Pediatr Infect Dis J; 2017 May; 36(5):486-491. PubMed ID: 28403050
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of BMY 28100, a new oral cephalosporin.
    Steele J, Edwards B, Rissing J.
    Eur J Clin Microbiol; 1987 Feb; 6(1):111-3. PubMed ID: 3494601
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vitro activity of amoxicillin and ampicillin against bacteria isolated from ill children.
    Marks MI.
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1137-44. PubMed ID: 4154827
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.